In the current study, Kaplan–Meier survival analysis showed that the OS and DFS of PTK6-positive patients were lower than those PTK6-negative patients in the LNM + group, which also confirmed that PTK6 was associated with poor prognosis of breast cancer. Here, PTK6 is linked to breast carcinoma.